NCT06126471View on ClinicalTrials.gov

Prevalence and Pathological Features of C3 Dominant Glomerulonephritis Among Egyptian Population

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

December 31, 2024

Conditions

C3 Nephropathy

Trial Locations (1)

Unknown

RECRUITING

Sohag university , faculty of medicine, Sohag

All Listed Sponsors

lead

Sohag University

OTHER